Sarepta Therapeutics Inc (NASDAQ:SRPT)

Delayed Data
As of Mar 16
 -0.30 / -0.37%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 75.00, with a high estimate of 101.00 and a low estimate of 55.00. The median estimate represents a -7.32% decrease from the last price of 80.92.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 24.86%
Growthannually -30.10%


Growthquarterly 10.99%
Growthannually 96.76%
Key to the earnings and sales forecast charts.